| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |